S L Perkins

1.7k total citations
40 papers, 1.0k citations indexed

About

S L Perkins is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, S L Perkins has authored 40 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Oncology and 11 papers in Pathology and Forensic Medicine. Recurrent topics in S L Perkins's work include Lymphoma Diagnosis and Treatment (9 papers), Acute Lymphoblastic Leukemia research (4 papers) and Bone Metabolism and Diseases (4 papers). S L Perkins is often cited by papers focused on Lymphoma Diagnosis and Treatment (9 papers), Acute Lymphoblastic Leukemia research (4 papers) and Bone Metabolism and Diseases (4 papers). S L Perkins collaborates with scholars based in United States, France and United Kingdom. S L Perkins's co-authors include Donald E. Kohan, Anne K. Hughes, Steven L. Teitelbaum, Carl R. Kjeldsberg, Glenn H. Segal, Thomas G. Gross, Stefan Schreiber, Sajjad Hussain, Rodney R. Miles and Paul J. Galardy and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

S L Perkins

37 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S L Perkins United States 19 438 393 294 163 108 40 1.0k
K Mukai Japan 20 355 0.8× 452 1.2× 436 1.5× 194 1.2× 110 1.0× 41 1.3k
Gerlinde Mitterbauer Austria 27 645 1.5× 223 0.6× 204 0.7× 428 2.6× 24 0.2× 57 1.8k
Enrico Gottardi Italy 24 1.4k 3.2× 330 0.8× 332 1.1× 224 1.4× 34 0.3× 79 3.7k
Juan Bergua Spain 21 979 2.2× 739 1.9× 328 1.1× 730 4.5× 117 1.1× 59 2.3k
Anna Benet‐Pagès Germany 15 958 2.2× 448 1.1× 327 1.1× 102 0.6× 23 0.2× 34 2.5k
Masaaki Noguchi Japan 14 245 0.6× 180 0.5× 261 0.9× 163 1.0× 111 1.0× 85 866
Anthony J. Apicelli United States 16 511 1.2× 264 0.7× 41 0.1× 148 0.9× 101 0.9× 29 1.0k
H. Behrendt Netherlands 24 325 0.7× 259 0.7× 368 1.3× 130 0.8× 209 1.9× 74 1.5k
Janet L. Parkin United States 20 343 0.8× 164 0.4× 187 0.6× 321 2.0× 20 0.2× 33 1.2k
Mara Dominis Croatia 15 541 1.2× 183 0.5× 122 0.4× 142 0.9× 55 0.5× 65 1.1k

Countries citing papers authored by S L Perkins

Since Specialization
Citations

This map shows the geographic impact of S L Perkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S L Perkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S L Perkins more than expected).

Fields of papers citing papers by S L Perkins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S L Perkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S L Perkins. The network helps show where S L Perkins may publish in the future.

Co-authorship network of co-authors of S L Perkins

This figure shows the co-authorship network connecting the top 25 collaborators of S L Perkins. A scholar is included among the top collaborators of S L Perkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S L Perkins. S L Perkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klinger, Mark, Jianbiao Zheng, Kojo S.J. Elenitoba‐Johnson, et al.. (2015). Next-generation IgVH sequencing CLL-like monoclonal B-cell lymphocytosis reveals frequent oligoclonality and ongoing hypermutation. Leukemia. 30(5). 1055–1061. 15 indexed citations
2.
Zhou, Jiehao, Koen van Besien, Attilio Orazi, et al.. (2014). Infectious Disease Pathology. Modern Pathology. 27. 390–394. 12 indexed citations
3.
El‐Mallawany, Nader Kim, J. Kimble Frazer, Pieter Van Vlierberghe, et al.. (2012). Pediatric T- and NK-cell lymphomas: new biologic insights and treatment strategies. Blood Cancer Journal. 2(4). e65–e65. 18 indexed citations
4.
Kelley, Todd W., S.C. Jacobsen, Alan C. Tripp, et al.. (2011). Informatics. Modern Pathology. 24. 339–343.
5.
Hussain, Sajjad, Oded Foreman, S L Perkins, et al.. (2010). The de-ubiquitinase UCH-L1 is an oncogene that drives the development of lymphoma in vivo by deregulating PHLPP1 and Akt signaling. Leukemia. 24(9). 1641–1655. 105 indexed citations
6.
8.
Perkins, S L, James O. Murphy, Bonnie S. Barr, et al.. (2006). Prevalence of gastric squamous ulceration in horses with abdominal pain. Equine Veterinary Journal. 38(4). 347–349. 23 indexed citations
9.
Kelly, Kara M., Ray Hutchinson, Richard Sposto, et al.. (2002). Feasibility of upfront dose‐intensive chemotherapy in children with advanced‐stage Hodgkin's lymphoma: preliminary results from the Children's Cancer Group Study CCG‐59704. Annals of Oncology. 13. 107–111. 38 indexed citations
10.
Lones, Mark A., A. Aupérin, Martine Raphaël, et al.. (2000). Mature B-cell lymphoma/leukemia in children and adolescents: Intergroup pathologist consensus with the Revised European—American Lymphoma Classification. Annals of Oncology. 11(1). 47–52. 26 indexed citations
11.
Rubin, Janet, Diane M. Biskobing, Dongjie Fan, et al.. (1998). Dexamethasone Promotes Expression of Membrane-Bound Macrophage Colony-Stimulating Factor in Murine Osteoblast-Like Cells1. Endocrinology. 139(3). 1006–1012. 85 indexed citations
12.
Brown, K A, et al.. (1996). bcl-2 is down-regulated in atypical endometrial hyperplasia and adenocarcinoma.. PubMed. 9(4). 430–8. 39 indexed citations
13.
Perkins, S L, et al.. (1995). 1,25 dihydroxyvitamin D3 stimulates differentiation of committed murine bone marrow-derived macrophage precursor cells.. Endocrinology. 136(12). 5643–5650. 10 indexed citations
14.
Perkins, S L, Glenn H. Segal, & Carl R. Kjeldsberg. (1995). Classification of non-Hodgkin's lymphomas in children.. PubMed. 12(4). 303–13. 23 indexed citations
15.
Lacey, David L., et al.. (1994). Interleukin 4 enhances osteoblast macrophage colony-stimulating factor, but not interleukin 6, production. Calcified Tissue International. 55(1). 21–28. 14 indexed citations
16.
Perkins, S L, et al.. (1994). Age-related bone loss in mice is associated with an increased osteoclast progenitor pool. Bone. 15(1). 65–72. 58 indexed citations
17.
Schreiber, Stefan, William F. Stenson, Richard P. MacDermott, et al.. (1991). Aggregated bovine IgG inhibits mannose receptor expression of murine bone marrow-derived macrophages via activation. The Journal of Immunology. 147(4). 1377–1382. 6 indexed citations
18.
Schreiber, Stefan, Janice S. Blum, William F. Stenson, et al.. (1991). Monomeric IgG2a promotes maturation of bone-marrow macrophages and expression of the mannose receptor.. Proceedings of the National Academy of Sciences. 88(5). 1616–1620. 19 indexed citations
19.
Fritz, V U, et al.. (1983). Motor neuron disease associated with carcinoma. South African Medical Journal. 68(8). 288–291. 3 indexed citations
20.
Perkins, S L, et al.. (1983). Motor neuron disease associated with carcinoma. A report of 2 cases.. PubMed. 63(8). 288–91. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026